Ardent Equine, a biotechnology company dedicated to improving and advancing equine healthcare, has collaborated with Pegasus Orthobiologics, a new facility focused on laboratory service biologic therapies. This partnership brings together leading scientists and equine sports medicine professionals, leveraging their combined expertise to revolutionize orthobiologic treatments in veterinary medicine. With the rise of regenerative therapy in both human and animal medicine, veterinarians are seeking alternative treatment options for their patients. These laboratory services will eliminate the need for equipment as well as reduce patient-to-patient variability and time associated with orthobiologics.
Regenerative medicine is often not a one-size-fits-all approach, and multiple studies have outlined the importance of optimizing and tailoring the composition of biologics. Driven by a mutual passion for Regenerative Medicine and a commitment to elevating care standards, Ardent Equine has partnered with Drs. Phillipe Benoit, Omar Maher, and Lauren Schnabel of Pegasus Orthobiologics to not only streamline the process of orthobiologic treatments, but also tailor these treatments to the specific needs of each injury to enhance the healing process and improve outcomes.
“We are thrilled to join forces with Pegasus Orthobiologics and their exceptional team of veterinarians. This partnership fuels our shared dedication to advancing regenerative medicine and improving treatment consistency across all patients,” stated Emma Partridge, the laboratory scientist at Ardent Equine.
“Pegasus’ long-term goals extend beyond Platelet Rich Plasma (PRP) preparation; we are also eager to improve and standardize the processing of other orthobiologics, such as Autologous Conditioned Serum (ACS). Collaborating with Ardent Equine allows Pegasus to take significant strides toward this goal,” stated Benoit.
For the full release, visit: https://ardentequine.com/ardent-pegasus/.
About Ardent Equine
Ardent Equine now offers Elevate Conditioned Serum (ECS), a blood-based laboratory service designed for the busy veterinarian. ECS is an autologous biologic that contains concentrated amounts of cytokines and growth factors such as IL-1Ra, IL-10, IL-4, and TGF-β1, which are essential for mediating inflammation and promoting tissue healing. This service delivers a high volume of final product, offering veterinarians enough serum for a comprehensive treatment strategy. With no need for specialized equipment or hands-on processing time, ECS provides a convenient and effective solution for integrating regenerative medicine into veterinary practice.
About Pegasus Orthobiologics
Pegasus Orthobiologics addresses the critical problem of inconsistent and low-efficacy PRP by processing blood samples with a method that standardizes the leukocyte and platelet concentrations and guarantees extremely low red and white blood cell counts. Our groundbreaking technology also allows us to tailor the platelet concentration to the specific joint being treated. Consequently, Pegasus delivers high-efficacy PRP, transforming what can be a hit-or-miss therapy into a consistently effective and standardized treatment. Pegasus’ long-term goals extend beyond PRP preparation; we are also eager to improve and standardize the processing of other orthobiologics, such as ACS. Collaborating with Ardent Equine allows Pegasus to take significant strides toward this goal. Grounded in a mutual passion for equine welfare and a commitment to elevating care standards, our partnership allows us to provide the highest-quality, safest orthobiologics available today.
Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.
